GlassScriptPhysician profile
Kyle Smothers
NPI 1942707021
$2,114.49
in general payments reported to CMS, 2019-2025
18 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.54 · 2022: $567 · 2023: $354 · 2024: $811 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,534.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $444.28 | 2022 | |
| Inspire Medical Systems, INC. | $429.46 | 2023-2025 | Inspire |
| Aerin Medical INC. | $256.99 | 2024-2025 | |
| Cochlear Americas | $238.39 | 2024 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Genzyme Corporation | $130.25 | 2023-2025 | |
| Medtronic, INC. | $122.42 | 2022 | |
| Ambu INC. | $121.37 | 2023 | |
| Glaxosmithkline, LLC. | $94.81 | 2023-2025 | Nucala |
| Hologic Sales and Service, LLC | $65.84 | 2025 | Coolseal Generator |
| Integra Lifesciences Corporation | $31.89 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Neurent Medical Limited | $31.47 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Acclarent, INC | $30.50 | 2023-2024 | Trudi Nav Cable, Acclarent Aera, Relieva Tract |
| Vertex Pharmaceuticals Incorporated | $28.38 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $25.41 | 2025 | Dupixent |
| Advanced Bionics, LLC | $20.00 | 2025 | Hires Ultra Ci Hifocus Ms Electrode |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $16.24 | 2023 | |
| Merck Sharp & Dohme LLC | $13.54 | 2021 | |
| Karl Storz Endoscopy-America | $13.25 | 2023 | N.A. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Smothers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.